Options Market Signals Scope of Federal Reserve Interventions
Traders see an implicit promise beyond specific asset purchases
Cause and Effect in the Complex World of Corporate Decision Making
As with scientific research, it’s hard to distinguish correlation from causation
Sales Promotions Influence People Beyond Purchasing Decisions
Exposure to discounts makes people impatient
COVID Tested U.S. Health Systems — and its News Habits
Social media optimal for spreading conspiracy theories
Historical Case for Immigrants Sending Home More Than Money
France’s lower fertility rates spread to regions that sent the most emigrants to live there
As States Permitted Online Sports Gambling, Citizens’ Personal Financial Health Suffered
Half a trillion dollars wagered — and counting
Taking the Battle for Financial Literacy to Where the Eyeballs Are
Research by Bruce Carlin and Stephen Spiller suggests YouTube videos could help consumers make better money decisions
In U.S.-China Trade War, Bystander Countries Increase Exports
Higher demand from U.S. and China means expanding into new markets
Does Better Corporate Disclosure Boost Markets?
Stronger financial reporting standards seem to mean more for growth of countries’ credit markets than their stock markets
Retailing Cross-Platform Win: A Pop-Up Store Boosts Online Sales
Alibaba finds a fresh twist on an old-school store is an effective marketing tool
Do Fair Disclosure Rules Lead to More or Less Information?
Managers, forced to inform a broader audience, choose not to gather information even for themselves
The Surprising Relationship Between Empathic Skill — the Ability to Read Others’ Feelings — and One’s Own Happiness
A surer path to contentedness might be believing one possesses empathy, even if one doesn’t
Credit Scores, Used to Predict Repayment, Can Restrain Economic Recovery
Rigid adherence to scoring systems can reduce consumer spending when it’s most needed
Citizens Are Not Fooled by Fake Statistics
What happened when the Argentine government lied about inflation numbers?
Huge Spending — But Little Sharing of Research Results — on Cancer Drugs
U.S. efforts to encourage transparency widely ignored by companies
Should Manufacturers Use Formal Procedures to Evaluate Alternative Materials?
Methods that weight efficacy, toxicity and cost improve understanding but provide no easy answers